Terms: = Endocrine gland cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40 AND Treatment
7 results:
1. Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic cancer Therapies.
Roth HE; De Lima Leite A; Palermo NY; Powers R
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291603
[TBL] [Abstract] [Full Text] [Related]
2. Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
Moukarzel LA; Ferrando L; Dopeso H; Stylianou A; Basili T; Pareja F; Da Cruz Paula A; Zoppoli G; Abu-Rustum NR; Reis-Filho JS; Long Roche K; Tew WP; Chi DS; Sonoda Y; Zamarin D; Aghajanian C; O'Cearbhaill RE; Zivanovic O; Weigelt B
Gynecol Oncol; 2022 May; 165(2):239-247. PubMed ID: 35292180
[TBL] [Abstract] [Full Text] [Related]
3. treatment strategies for giant pituitary adenomas in the era of endoscopic transsphenoidal surgery: a multicenter series.
Micko A; Agam MS; Brunswick A; Strickland BA; Rutkowski MJ; Carmichael JD; Shiroishi MS; Zada G; Knosp E; Wolfsberger S
J Neurosurg; 2022 Mar; 136(3):776-785. PubMed ID: 34388714
[TBL] [Abstract] [Full Text] [Related]
4. ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors.
Duncan RM; Reyes L; Moats K; Robinson RM; Murphy SA; Kaur B; Stessman HAF; Dolloff NG
Cancer Res; 2020 Aug; 80(16):3279-3291. PubMed ID: 32561529
[TBL] [Abstract] [Full Text] [Related]
5. dnajb1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
[TBL] [Abstract] [Full Text] [Related]
6. Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas.
Takesue Y; Wei FY; Fukuda H; Tanoue Y; Yamamoto T; Chujo T; Shinojima N; Yano S; Morioka M; Mukasa A; Kuratsu J; Tomizawa K
Endocr J; 2019 Sep; 66(9):807-816. PubMed ID: 31189758
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of treatment and survival after positive second-look laparotomy.
Podratz KC; Schray MF; Wieand HS; Edmonson JH; Jefferies JA; Long HJ; Malkasian GD; Stanhope CR; Wilson TO
Gynecol Oncol; 1988 Sep; 31(1):9-24. PubMed ID: 3410358
[TBL] [Abstract] [Full Text] [Related]
